Abstrakt
Diagnostic panel for prediction of the presence of primary or recurrent urothelial bladder cancer. The combination of midkine and synuclein increases the accuracy of tumor detection in cystoscopy as compared to negative controls.
Diagnostic panel for prediction of the presence of primary or recurrent urothelial bladder cancer. The combination of midkine and synuclein increases the accuracy of tumor detection in cystoscopy as compared to negative controls.